Bridgeway Capital Management’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Bridgeway Capital Management’s Portfolio AST.WS Stock Details AST.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-29,609	Closed	-$15K	–	1509
2017 Q2	$15K	Hold	29,609	–	–	﹤0.01%	1407
2017 Q1	$13K	Hold	29,609	–	–	﹤0.01%	1381
2016 Q4	$16K	Hold	29,609	–	–	﹤0.01%	1396
2016 Q3	$15K	Sell	29,609 -1	-0%	–	﹤0.01%	1417
2016 Q2	$6K	Buy	+29,610	New	+$15.4K	﹤0.01%	1427

Bridgeway Capital Management's AST.WS Position: Q3 2017 in Review

Bridgeway Capital Management sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 29,609 shares — an estimated $15K sold.

Bridgeway Capital Management first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $16K in Q4 2016. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

Bridgeway Capital Management reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
Bridgeway Capital Management sold 29,609 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017, an estimated $15K.
Bridgeway Capital Management first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
Bridgeway Capital Management's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $16K in Q4 2016.
3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on Bridgeway Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.